Tuesday, August 24, 2021

New Technologies that Aim to Help the Environment


via WordPress https://ift.tt/3D9ZV4J

C16 Biosciences Palm Oil Through

A California-based company, SP Investment Fund is a multi-faceted socially positive investment company that invests in multi-family family real estate and also invests in in emerging health sciences and biotechnologies companies such as C16 Biosciences.

C16 Biosciences is a company that wants to create sustainable and environmentally friendly palm oil. Palm oil can be found in everything nowadays, in clothes, shampoo, and even fuel. To create palm oil, companies destroy rainforests in countries such as Costa Rica and Indonesia to plant palm oil trees. This act can destroy the habitats of people living in nearby areas and endanger wildlife.

The palm oil developed by C16 Biosciences is sustainable and does not come from palm oil trees. Therefore, it does not endanger species of animals or cause deforestation. The alternative palm oil proposed by C16 Biosciences is obtained through fermentation and brewing. In this way, the company can reduce the footprint left by the production of palm oil and not harm the environment and the people and animals living in it.

Monday, June 21, 2021

HepaTx Collaboration Reports 95 Percent Success Rate in Second Phase


via WordPress https://ift.tt/35J4aEU

c16 Biosciences Moves Lab Inside Hudson

Based in Los Angeles, SP Investment Fund, LLC, has managed investments in affordable housing and technology and life science start-ups for more than three decades. One company that SP Investment Fund was an early investor in is c16 Biosciences, Inc., a company working to develop an environmentally friendly and sustainable alternative to conflict palm oil.

Having recently received financing through Bill Gates's Breakthrough Energy Ventures Fund, c16 Biosciences is relocating its biomanufacturing research facility and executive headquarters to the Hudson Research Center, located at 619 West 54th Street in New York City. The space spans 20,000 square feet on the seventh floor and features preexisting office and lab amenities.

In its new location, c16 Biosciences will utilize microbiology to brew alternatives to conflict palm oil, which is used to manufacture a wide range of everyday consumer products. The global conflict palm oil industry is valued at $61 billion. In creating an alternative, the company seeks to protect wildlife, land, and natural resources. It formerly operated at 180 Varick Street, which housed its incubator facility.

Wednesday, March 17, 2021

Why Limited Partners Sell Interests in Affordable Housing


via WordPress https://ift.tt/3cIrRAe

Synkrino - A Beneficiary of UC Berkeley’s



Headquartered in Los Angeles, California, SP Investment Fund invests in social positive investments in affordable housing and in emerging technology companies that solve big problems. One such emerging technology company that SP has invested in is SF17 Therapeutics, which recently changed its name to Synkrino.

Synkrino leverages artificial intelligence to develop precision immune therapies. The company uses patient-generated data to develop targeted treatments for both complex auto-inflammatory and auto-immune diseases. It was part of Y Combinator’s 2018 cohort and even joined the CITRIS Foundry portfolio of science companies that same year.

CITRIS Foundry is a highly competitive program by UC Berkeley that helps innovators make an impact in the world. The innovation hub selects a committed group of entrepreneurs every year and gives them access to the university’s resources, enabling them to leapfrog their innovations from conception to commercialization.

The program only admits transformative technologies with the potential to affect their industries positively. The program provides entrepreneurs with access to UC Berkeley’s specialized laboratories, on-campus workspace to accommodate growing teams, and direct support from Foundry Fellows drawn from the Haas School of Business, College of Engineering.

Since its founding in 2013, CITRIS Foundry has supported 65 projects and raised more than $100 million. Other companies chosen alongside Synkrino in the CITRIS Foundry 2018 group were Threestone Analytics and Corshell Technologies.